Evidence map›Paper›PMID 35528152›Full record

ReviewActa clinica Croatica2021

OPPORTUNISTIC SCREENING FOR COLORECTAL CANCER IN HIGH-RISK PATIENTS IN FAMILY MEDICINE PRACTICES IN THE REPUBLIC OF CROATIA.

Neven Ljubičić, Goran Poropat, Nataša Antoljak, Nina Bašić Marković, Vjekoslava Amerl Šakić, Marko Rađa, Dragan Soldo, Davor Štimac, Mirjana Kalauz, Hrvoje Iveković and 4 more

Open access · diamondAbstract readReview
In one paragraph

Review in Acta clinica Croatica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Neven LjubičićSchool of Medicine, University of Zagreb, Zagreb, Croatia.
Goran PoropatSchool of Medicine, University of Rijeka, Rijeka, Croatia.
Nataša AntoljakSchool of Medicine, University of Zagreb, Zagreb, Croatia.
Nina Bašić MarkovićSchool of Medicine, University of Rijeka, Rijeka, Croatia.
Vjekoslava Amerl ŠakićVjekoslava Amerl Šakić Family Medicine Practice, Zagreb, Croatia.
Marko RađaHealthcare Center of the Split-Dalmatia County, Split, Croatia.
Dragan SoldoSchool of Medicine, University of Zagreb, Zagreb, Croatia.
Davor ŠtimacSchool of Medicine, University of Zagreb, Zagreb, Croatia.
Mirjana KalauzSchool of Medicine, University of Zagreb, Zagreb, Croatia.
Hrvoje IvekovićCroatian Society of Gastroenterology, Zagreb, Croatia.
Marko BanićSchool of Medicine, University of Zagreb, Zagreb, Croatia.
Franjo TuralijaNational Monitoring Committee for the Implementation of the National Colon Cancer Early Detection Program of the Croatian Ministry of Health, Zagreb, Croatia.
Željko PuljizCroatian Society of Gastroenterology, Zagreb, Croatia.
Ivana Brkić BilošNational Monitoring Committee for the Implementation of the National Colon Cancer Early Detection Program of the Croatian Ministry of Health, Zagreb, Croatia.
Sisters of Charity Hospital · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is a malignant neoplasm which has an increasing incidence and represents a global public health problem. The majority of patients are diagnosed after the age of 50, and the risk of developing it over lifetime is 5%. Development of preventive, diagnostic and treatment methods has resulted in a significant reduction in mortality and other negative clinical outcomes. Precisely because of the efficient method of prevention and early detection of this disease, numerous countries, including Croatia, have organized national colorectal cancer screening and monitoring programs. However, these programs are primarily organized for the population with the usual, i.e. average risk of developing colorectal cancer. High-risk groups include persons with endoscopically detected and removed colon polyps, persons surgically treated for colon cancer, persons with a positive family history of colorectal cancer, persons with inflammatory bowel diseases, individuals and families with hereditary disorders or genetic mutations that increase the risk of this disease several fold, persons with acromegaly, and patients who have undergone ureterosigmoidostomy. Recommendations for the detection and monitoring of high-risk groups are often not defined clearly, and some of the existing ones are based mostly on scarce scientific evidence. It is commonly accepted that screening in high-risk groups should start at an earlier age, with shorter intervals between follow-ups. The basic diagnostic method for screening and monitoring in these patient groups is endoscopic monitoring, or colonoscopy. The aim of this review paper is to present the characteristics of the abovementioned risk groups and provide clear screening recommendations.

Indexed as

Colorectal NeoplasmsOccult BloodCroatiaEarly Detection of CancerFamily PracticeHumansColorectal cancerFamily medicineOpportunistic screening

Identifiers

PMID35528152
PMCPMC9036274
OpenAlexW4285507901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.